Stock Traders Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was the target of unusually large options trading activity on Wednesday. Traders purchased 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the average volume of 53 put options.

Analyst Ratings Changes

MRVI has been the subject of a number of research reports. Robert W. Baird dropped their target price on shares of Maravai LifeSciences from $10.00 to $9.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Guggenheim started coverage on shares of Maravai LifeSciences in a research note on Thursday, December 19th. They issued a “neutral” rating for the company. Royal Bank of Canada decreased their target price on shares of Maravai LifeSciences from $17.00 to $13.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. The Goldman Sachs Group cut Maravai LifeSciences from a “neutral” rating to a “sell” rating and dropped their price target for the company from $7.00 to $4.25 in a research note on Thursday, December 5th. Finally, William Blair reissued a “market perform” rating on shares of Maravai LifeSciences in a report on Friday, November 8th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Maravai LifeSciences currently has an average rating of “Hold” and a consensus target price of $10.28.

Maravai LifeSciences Trading Up 3.9 %

NASDAQ MRVI opened at $5.33 on Thursday. The firm has a market capitalization of $1.35 billion, a PE ratio of -3.25 and a beta of -0.07. The business’s 50-day moving average price is $6.12 and its two-hundred day moving average price is $7.55. The company has a current ratio of 10.74, a quick ratio of 9.94 and a debt-to-equity ratio of 0.89. Maravai LifeSciences has a 12 month low of $4.28 and a 12 month high of $11.56.

Insider Buying and Selling

In other Maravai LifeSciences news, insider Carl Hull acquired 175,000 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average cost of $5.64 per share, for a total transaction of $987,000.00. Following the transaction, the insider now directly owns 175,000 shares in the company, valued at $987,000. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.63% of the stock is currently owned by company insiders.

Institutional Trading of Maravai LifeSciences

Institutional investors have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Maravai LifeSciences in the 2nd quarter worth approximately $32,000. Venturi Wealth Management LLC bought a new position in Maravai LifeSciences during the third quarter worth $47,000. Custom Index Systems LLC acquired a new position in Maravai LifeSciences in the third quarter valued at $97,000. Y Intercept Hong Kong Ltd acquired a new stake in Maravai LifeSciences during the 3rd quarter worth about $105,000. Finally, Headlands Technologies LLC grew its holdings in Maravai LifeSciences by 205.9% during the 2nd quarter. Headlands Technologies LLC now owns 14,935 shares of the company’s stock worth $107,000 after acquiring an additional 10,053 shares during the period. 50.25% of the stock is currently owned by institutional investors.

About Maravai LifeSciences

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.